See how Ceribell’s point-of-care EEG is reducing length of stay and transforming patient care in the ICU.
1/3 of neurological critical care patients are at risk for seizures, which may lead to permanent brain injury and increased risk of death. 3,4
— Indications for Emergent EEG —
AI-powered point-of-care EEG that delivers results to the ICU in minutes for patients at risk of seizures
References and citations
1. Desai, M., et al. (2024) Neurocrit Care
2. Vespa, P.M., et al. (2020) Crit Care Med. 48(9):1249-1257
3. Laccheo, I., et al. (2015) Neurocrit Care. 22:202-211
4. De Marchis, G.M., et al. (2016) Neurology. 86(3):253-260
5. Herman, S.T., et al. (2015) J Clin Neurophysiol. 32(2):87-95
6. Panchal, A.R., et al. (2020) Circulation. 142(suppl 2):S366-S468
7. Perman S.M., et al. (2023) Circulation 149(5):e254-e273
8. Lowenstein, D.H., et al. (1993) Neurology, 43(3 Pt 1):483-488
9. Young, G.B., et al. (1996). Neurology, 47(1):83-89
*Using mRS greater than or equal to 4 at discharge as an indicator of functional disability. Results with Ceribell vs. conventional EEG
† Non-convulsive seizure prevalence specifically
Caution: Device does not substitute for EEG review by a qualified clinician. Before use, review the manual for indications, contraindications, warnings, precautions, potential adverse events and Instructions for Use. Sale requires the order of a physician.
©2024 Ceribell Inc., All Rights Reserved